Maker's videoMicroPort · 13 Feb 2024
Our pursuit of patient-led innovation has led us to pioneer world firsts
Against the record
Toumai, from MicroPort MedBot (MicroPort group), is at stage 5 of 5 on our ladder: regulator-cleared or mass market. Cleared where approval applies, or widely sold. The latest milestone on its record is from 22 July 2026: MicroPort MedBot, Toumai's maker, said it expected its first-ever half-year profit, of about 28 to 40 million yuan.
This video comes from the maker's own channel, and makers show their robots at their best. The stage above comes from dated public records, not from the video.
From the video's description
Our pursuit of patient-led innovation has led us to pioneer world firsts - helping us reshape millions of lives globally for over #Proudly25Years. We will keep providing patients with the best possible care in 2024 so they can live #BetterAndLongerLives. Learn more: https://microport.com/. Follow us on LinkedIn: www.linkedin.com/company/microport/. Follow us on Twitter: www.twitter.com/MicroPort.
Written by MicroPort on YouTube.
More videos of Toumai
Cutting-edge robotic surgery solutions | MicroPort® MedBot™
Cutting-edge robotic surgery solutions | MicroPort® MedBot™
Medical technologies that benefit a patient every 5 seconds | MicroPort®
Medical technologies that benefit a patient every 5 seconds | MicroPort®
Fostering medical innovation that improves patient outcomes | MicroPort®
Fostering medical innovation that improves patient outcomes | MicroPort®